Ryazhenov, V V

Issue Section Title Abstract File
Vol 18, No 3 (2016) Articles Clinico-economic evaluation of different treatment strategies in patients with non-small cell lung cancer and mutations in the EGFR gene Abstract PDF
(Rus)
Vol 19, No 1 (2017) Articles The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor Abstract PDF
(Rus)
Vol 13, No 3 (2011) Articles Analiz zabolevaemosti rakommolochnoy zhelezy s uchetom statusa HER2na territorii Rossiyskoy Federatsii Abstract
Vol 14, No 3 (2012) Articles Ispol'zovanie pokazatelya effektivnosti zatrat pri kompleksnoy farmakoekonomicheskoy otsenke dorogostoyashchikh meditsinskikh tekhnologiy. Primer bevatsizumaba Abstract
Vol 14, No 3 (2012) Articles Prognozirovanie zabolevaemosti rakom molochnoy zhelezy s vydeleniem populyatsii patsientov s giperekspressiey HER2 v Sibirskom federal'nom okruge Abstract

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies